| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 24/09/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:SILK | Silk Road Medical Inc |
| 19/09/2024 | 02:56 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SILK | Silk Road Medical Inc |
| 17/09/2024 | 15:12 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SILK | Silk Road Medical Inc |
| 17/09/2024 | 14:46 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:SILK | Silk Road Medical Inc |
| 17/09/2024 | 14:46 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SILK | Silk Road Medical Inc |
| 17/09/2024 | 14:31 | PR Newswire (US) | Boston Scientific Closes Acquisition of Silk Road Medical, Inc. | NASDAQ:SILK | Silk Road Medical Inc |
| 28/08/2024 | 12:01 | Edgar (US Regulatory) | Form DEFR14A - Revised definitive proxy soliciting materials | NASDAQ:SILK | Silk Road Medical Inc |
| 07/08/2024 | 22:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:SILK | Silk Road Medical Inc |
| 07/08/2024 | 22:05 | GlobeNewswire Inc. | Silk Road Medical Reports Second Quarter 2024 Financial Results | NASDAQ:SILK | Silk Road Medical Inc |
| 30/07/2024 | 14:00 | GlobeNewswire Inc. | Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures | NASDAQ:SILK | Silk Road Medical Inc |
| 29/07/2024 | 12:01 | Edgar (US Regulatory) | Form DEFM14A - Definitive proxy statement relating to merger or acquisition | NASDAQ:SILK | Silk Road Medical Inc |
| 19/07/2024 | 23:28 | Edgar (US Regulatory) | Form PREM14A - Preliminary proxy statements relating to merger or acquisition | NASDAQ:SILK | Silk Road Medical Inc |
| 19/07/2024 | 15:47 | PR Newswire (US) | Kuehn Law Encourages SILK, SGE, AAN, and PRMW Investors to Contact Law Firm | NASDAQ:SILK | Silk Road Medical Inc |
| 10/07/2024 | 19:45 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] | NASDAQ:SILK | Silk Road Medical Inc |
| 18/06/2024 | 23:20 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:SILK | Silk Road Medical Inc |
| 18/06/2024 | 19:23 | PR Newswire (US) | ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc. | NASDAQ:SILK | Silk Road Medical Inc |
| 18/06/2024 | 13:00 | PR Newswire (US) | Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc. | NASDAQ:SILK | Silk Road Medical Inc |
| 18/06/2024 | 13:00 | GlobeNewswire Inc. | Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific | NASDAQ:SILK | Silk Road Medical Inc |
| 30/05/2024 | 22:12 | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NASDAQ:SILK | Silk Road Medical Inc |
| 30/04/2024 | 22:05 | GlobeNewswire Inc. | Silk Road Medical Reports First Quarter 2024 Financial Results | NASDAQ:SILK | Silk Road Medical Inc |
| 23/04/2024 | 22:30 | GlobeNewswire Inc. | Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference | NASDAQ:SILK | Silk Road Medical Inc |
| 09/04/2024 | 22:30 | GlobeNewswire Inc. | Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024 | NASDAQ:SILK | Silk Road Medical Inc |
| 02/04/2024 | 22:30 | GlobeNewswire Inc. | Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS | NASDAQ:SILK | Silk Road Medical Inc |
| 05/03/2024 | 23:23 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:SILK | Silk Road Medical Inc |
| 05/03/2024 | 15:00 | GlobeNewswire Inc. | Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System | NASDAQ:SILK | Silk Road Medical Inc |
| 28/02/2024 | 22:05 | GlobeNewswire Inc. | Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook | NASDAQ:SILK | Silk Road Medical Inc |
| 07/02/2024 | 22:30 | GlobeNewswire Inc. | Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 | NASDAQ:SILK | Silk Road Medical Inc |
| 20/12/2023 | 22:30 | GlobeNewswire Inc. | Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference | NASDAQ:SILK | Silk Road Medical Inc |
| 08/11/2023 | 22:05 | GlobeNewswire Inc. | Silk Road Medical Reports Third Quarter 2023 Financial Results | NASDAQ:SILK | Silk Road Medical Inc |
| 03/11/2023 | 23:47 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:SILK | Silk Road Medical Inc |